Related Experiment Video

Updated: Jun 10, 2026

Heterotypic Three-dimensional In Vitro Modeling of Stromal-Epithelial Interactions During Ovarian Cancer Initiation and Progression
12:42

Heterotypic Three-dimensional In Vitro Modeling of Stromal-Epithelial Interactions During Ovarian Cancer Initiation and Progression

Published on: August 28, 2012

Microcell-mediated chromosome transfer identifies EPB41L3 as a functional suppressor of epithelial ovarian cancers

Dimitra Dafou1, Barbara Grun, John Sinclair

  • 1EGA Institute for Women's Health, Gynaecological Cancer Research Laboratories, University College London, London, UK.

Neoplasia (New York, N.Y.)
|July 24, 2010
PubMed

Insights

Researchers identified EPB41L3 as a potential ovarian cancer suppressor gene. Reintroducing this gene into ovarian cancer cells halted tumor growth and induced cell death, suggesting its therapeutic potential.

Area of Science:

  • Oncology
  • Genetics
  • Molecular Biology

Background:

  • Ovarian cancer remains a significant health challenge with limited therapeutic options.
  • Identifying novel tumor suppressor genes is crucial for developing new ovarian cancer treatments.
  • Chromosome 18 transfer into ovarian cancer cells induced suppression, indicating the presence of tumor suppressor genes on this chromosome.

Purpose of the Study:

  • To identify tumor suppressor genes and potential therapeutic targets for ovarian cancer.
  • To investigate the role of EPB41L3 (erythrocyte membrane protein band 4.1-like 3) as a candidate ovarian cancer suppressor gene.

Main Methods:

  • Functional complementation using microcell-mediated chromosome transfer.
  • Gene expression microarray profiling to identify candidate genes.
  • Messenger RNA and protein expression analysis (immunoblot, immunohistochemistry).
  • Epigenetic analysis (methylation studies).
  • In vitro and in vivo functional studies (spheroid models, electron microscopy).

Main Results:

  • Chromosome 18 transfer suppressed neoplastic growth in ovarian cancer cells.
  • EPB41L3 was identified as a candidate tumor suppressor gene, overexpressed in hybrids and downregulated or absent in most ovarian tumors.
  • EPB41L3 inactivation in ovarian cancers is associated with promoter methylation.
  • Reexpression of EPB41L3 suppressed ovarian cancer cell growth and induced apoptosis in vitro and in 3D models.

Conclusions:

  • EPB41L3 functions as a tumor suppressor gene in ovarian cancer.
  • EPB41L3 inactivation, likely via methylation, contributes to ovarian tumorigenesis.
  • EPB41L3 reexpression demonstrates therapeutic potential for ovarian cancer treatment.

More Related Videos

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

Transplantation Into the Mouse Ovarian Fat Pad09:25

Transplantation Into the Mouse Ovarian Fat Pad

Published on: September 7, 2016

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...